IgG4-RD Clinical Trial
Official title:
An Open-label, Single-arm, Pilot Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease
The purpose of this Phase 2 study is to investigate the effect of XmAb5871 on IgG4-Related Disease (RD) activity
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04918147 -
Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
|
Phase 2 |